CSF-1 inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

BRAF V600K	Melanoma	BRAF V600K	Melanoma	trametinib + dabrafenib + MCS110 Sensitive: C3 – Early Trials trametinib + dabrafenib + MCS110 Sensitive : C3	trametinib + dabrafenib + MCS110 Sensitive: C3 – Early Trials trametinib + dabrafenib + MCS110 Sensitive : C3
BRAF V600E	Melanoma	BRAF V600E	Melanoma	trametinib + dabrafenib + MCS110 Sensitive: C3 – Early Trials trametinib + dabrafenib + MCS110 Sensitive : C3	trametinib + dabrafenib + MCS110 Sensitive: C3 – Early Trials trametinib + dabrafenib + MCS110 Sensitive : C3

Associations(2)